I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Diabetic Retinopathy: Protecting Your Vision
Understanding Diabetic Retinopathy
Diabetic retinopathy is a complication of diabetes that causes progressive damage to the blood vessels inside the eye. Knowing how and why this damage occurs is the foundation for managing it effectively and catching it early.
Diabetic retinopathy occurs when high blood sugar levels damage the tiny blood vessels that supply the retina with oxygen and nutrients. The retina is a thin layer of tissue lining the back of the eye that detects light and sends visual signals to the brain through the optic nerve. When these vessels are weakened over time, they can leak fluid or blood, swell, or close off entirely, threatening the eye's ability to function normally.
Sustained elevations in blood sugar cause structural changes to the small vessels nourishing the retina. As those vessels weaken, they may begin to leak blood or fluid into the surrounding tissue. When circulation to the retina becomes impaired, the eye produces a chemical signal called vascular endothelial growth factor, or VEGF. VEGF drives the growth of new, abnormal blood vessels on the surface of the retina, a process known as neovascularization, which marks the transition to a more dangerous phase of the disease.
Diabetic retinopathy is classified into two broad stages based on the extent of damage and whether abnormal new vessels have begun to grow.
The first stage is called non-proliferative diabetic retinopathy, or NPDR. In NPDR, retinal blood vessels weaken, develop small bulges called microaneurysms, and may begin to leak fluid or blood. Many people experience no noticeable vision changes during this stage, which is precisely why routine screening is so important.
The second and more serious stage is proliferative diabetic retinopathy, or PDR. In PDR, fragile new blood vessels grow on the retinal surface and can bleed into the vitreous (the gel that fills the inside of the eye). These vessels may also produce scar tissue that pulls on the retina and causes a detachment. In the most severe cases, abnormal vessels grow onto the iris (the colored part of the eye) and block its drainage system, leading to dangerously elevated eye pressure known as neovascular glaucoma.
Diabetic macular edema, or DME, occurs when damaged blood vessels leak fluid into the macula, the central part of the retina responsible for sharp, detailed vision. The macula is used for reading, recognizing faces, and performing close-detail tasks. When fluid accumulates and the macula swells, central vision becomes blurry or distorted. DME can develop at any stage of diabetic retinopathy and is one of the most frequent causes of diabetes-related vision loss.
Who Is at Risk
Anyone with diabetes can develop diabetic retinopathy, but certain factors raise that risk considerably. Understanding your personal risk profile helps determine how often you should be screened and how closely your condition needs to be watched.
Diabetic retinopathy is one of the most widespread causes of preventable blindness in the United States. According to the American Society of Retina Specialists, nearly 8 million Americans are currently living with the condition, and that number is projected to double by 2050. Globally, over 103 million adults were affected as of 2020, with projections estimating more than 160 million by 2045.
Diabetic retinopathy can develop in anyone diagnosed with type 1 diabetes, type 2 diabetes, or gestational diabetes, a form of the condition that arises during pregnancy. The longer a person has lived with diabetes, the greater their risk. Over time, more than half of all people with diabetes will develop some degree of retinopathy, making ongoing monitoring a lifelong priority.
Several factors increase the likelihood of developing diabetic retinopathy or experiencing faster progression of existing disease. Poor control of blood sugar, blood pressure, and cholesterol are among the most significant contributors to retinal damage over time.
- Long duration of diabetes
- Poorly controlled blood sugar levels
- High blood pressure
- High cholesterol
- Tobacco use
- Pregnancy in women with pre-existing diabetes
Women with diabetes who become pregnant face a heightened risk for diabetic retinopathy. Hormonal changes and blood sugar fluctuations during pregnancy can accelerate retinal damage, sometimes quite rapidly. If you have diabetes and are pregnant or planning to become pregnant, a dilated eye exam should be scheduled as early as possible. Our retina specialists can monitor your eyes throughout pregnancy and recommend treatment promptly if signs of progression appear.
Signs and Symptoms
One of the most challenging aspects of diabetic retinopathy is that it often causes no symptoms in its early stages. By the time vision changes become noticeable, the disease may have already advanced considerably, which is why regular screening matters even when your eyes feel completely normal.
In the early phases of NPDR, many people have no symptoms at all. Significant retinal damage can be present without any change in how clearly you see. Occasionally, some people notice mild difficulty reading or slight blurriness at a distance, but these changes can be subtle and easy to overlook or attribute to other causes such as fatigue or needing updated glasses.
As diabetic retinopathy progresses, symptoms become more apparent. Bleeding into the vitreous can produce dark floating spots or streaks that drift across your field of vision. Vision may become blurred or distorted, particularly when the macula is affected by swelling. In more advanced stages, shadows or patches of missing vision may also develop.
Certain visual changes should be treated as an emergency. If you experience any of the following, contact a retina specialist or go to an emergency room right away.
- A sudden increase in floaters or dark spots in your vision
- Flashes of light in one or both eyes
- A dark curtain or shadow moving across your visual field
- Sudden, severe vision loss in one eye
These symptoms can indicate a vitreous hemorrhage (bleeding inside the eye) or a retinal detachment, both of which require prompt evaluation and treatment to protect your vision.
How We Diagnose Diabetic Retinopathy
Accurate diagnosis requires both a thorough clinical examination and advanced imaging of the retina. Our practice uses a comprehensive set of diagnostic tools to detect diabetic retinopathy early, measure its severity, and track any changes between visits.
A comprehensive dilated eye exam is the most important tool for detecting diabetic retinopathy. Special drops are used to widen the pupils so our specialists can see the retina clearly. We examine the retina for leaking blood vessels, retinal swelling, fatty deposits, abnormal new vessel growth, and scar tissue. Because retinopathy can be present without symptoms, every person with diabetes should have a regular dilated eye exam regardless of whether their vision feels normal.
Optical coherence tomography, or OCT, is a non-invasive imaging test that creates detailed cross-sectional pictures of the retina. It measures retinal thickness and detects fluid accumulation in the macula with remarkable precision. OCT is especially useful for diagnosing and monitoring diabetic macular edema and for tracking how the retina responds to treatment over time. The scan is painless, takes only a few minutes, and provides information that cannot be gathered through a clinical exam alone.
Fluorescein angiography maps blood flow in the retina using a small amount of yellow dye injected into a vein in the arm. A specialized camera photographs the dye as it circulates through the retinal vessels, revealing areas of leakage, blockage, or abnormal vessel growth. This information guides treatment decisions in ways that standard imaging cannot always provide. We also use wide-field retinal imaging, OCT angiography, and indocyanine green (ICG) angiography when a more detailed view of retinal circulation is needed.
Treatment Options for Diabetic Retinopathy
Treatment depends on the stage of disease, the presence of diabetic macular edema, and each patient's overall health. Our retina specialists take an individualized approach to every patient, selecting therapies based on your specific findings, treatment history, and long-term goals.
Anti-VEGF injections are the most widely used and effective treatment for diabetic retinopathy and DME. These medications are injected directly into the vitreous cavity of the eye and work by blocking VEGF, the chemical signal responsible for abnormal vessel growth and fluid leakage. Several anti-VEGF medications are available, and your physician will recommend the option best suited to your condition and response to prior treatment.
- Eylea (aflibercept): FDA-approved for diabetic retinopathy and DME, typically given every four to eight weeks after an initial series of monthly injections
- Eylea HD (high-dose aflibercept): A higher-dose formulation approved for DME and diabetic retinopathy, with the potential for intervals of eight to sixteen weeks after loading doses
- Lucentis (ranibizumab): FDA-approved for diabetic retinopathy, generally administered every four weeks
- Avastin (bevacizumab): Used off-label for diabetic retinopathy and DME, with a long track record of use in retinal disease spanning nearly two decades
- Vabysmo (faricimab): A bispecific antibody approved for DME, with treatment intervals that may extend up to every sixteen weeks in some patients
Research has consistently shown that anti-VEGF injections can produce meaningful improvements in vision for many patients with DME, often with better results than laser treatment alone.
Laser therapy has been used to treat diabetic retinopathy for decades and remains an important tool, particularly for proliferative disease. Panretinal photocoagulation, or PRP, involves applying a pattern of laser spots to the peripheral retina. This reduces the retina's oxygen demand and helps suppress the growth of abnormal new vessels in PDR. Focal laser treatment targets specific leaking vessels near the macula. While anti-VEGF injections are now the preferred first-line treatment for DME, laser therapy continues to play a valuable role in managing advanced and complex cases.
Vitrectomy is a surgical procedure in which the vitreous gel is removed from inside the eye. It may be recommended when significant bleeding into the vitreous does not clear on its own, or when scar tissue is pulling on the retina and threatening a detachment. During the procedure, the vitreous is replaced with a saline solution or gas bubble, and additional steps may be taken as needed depending on what is found during surgery. Vitrectomy is typically performed at an outpatient surgical center by a fellowship-trained vitreoretinal surgeon.
For patients who require ongoing treatment, sustained-release options can reduce the number of office visits needed. Susvimo (ranibizumab injection) is an FDA-approved continuous drug delivery system that uses a small implant placed inside the eye to release medication over time, with refills needed approximately every nine months. Steroid-based implants such as Ozurdex (dexamethasone implant) may also be used for DME in selected patients, particularly those who have not responded well to anti-VEGF therapy. These options are always evaluated on a patient-by-patient basis.
Biosimilars are FDA-approved medications that have undergone rigorous testing and are considered highly similar in safety and effectiveness to the original biologic drugs they reference. Several biosimilars are now available for treating diabetic retinopathy and DME, including Ahzantive (aflibercept-mrbb), Byooviz (ranibizumab-nuna), and Cimerli (ranibizumab-eqrn). These medications expand the range of treatment choices available and may offer practical advantages for certain patients depending on their insurance coverage and clinical needs.
What to Expect During Treatment
Beginning treatment for diabetic retinopathy can feel unfamiliar, but most patients find the process manageable once they understand what is involved. Our team walks you through every step and makes your comfort and understanding a priority at each visit.
Intravitreal injections are performed in our office and take only a few minutes from start to finish. The eye is numbed with anesthetic drops and cleaned with an antiseptic solution before the procedure begins. The injection itself takes just a few seconds, and most patients feel a sensation of pressure rather than sharp pain, though some mild discomfort is normal. After the injection, you may notice temporary redness, mild irritation, or new floaters, all of which typically resolve within a few days.
Treatment for diabetic retinopathy is ongoing for most patients and requires consistent follow-up appointments. Anti-VEGF injections are usually given monthly during an initial loading phase, with intervals gradually extended based on how your eyes respond. Your retina specialist will track your progress using regular clinical exams and OCT imaging between treatments. Keeping all scheduled appointments is one of the most important commitments you can make to preserve your vision.
Treatment can stabilize vision and, in many cases, improve it, but outcomes vary from person to person. Some damage that has already occurred to the retina may not be fully reversible. The primary goal of treatment is to prevent further vision loss and preserve as much usable sight as possible. Early detection, consistent treatment, and well-managed diabetes together form the strongest foundation for protecting long-term visual health.
Living With Diabetic Retinopathy
A diagnosis of diabetic retinopathy does not mean vision loss is inevitable. With the right combination of medical care, diabetes management, and healthy daily habits, many people successfully manage this condition and maintain meaningful vision for years to come.
Controlling blood sugar, blood pressure, and cholesterol are the most impactful steps you can take between retina appointments to slow the progression of this disease. Working closely with your primary care physician or endocrinologist to keep your blood sugar within a recommended range is essential. Even modest, sustained improvements in blood sugar control can have a meaningful protective effect on the retina over the long term.
Because retinopathy can worsen without causing any noticeable symptoms, regular dilated eye exams are a critical part of diabetes management at every stage. Most clinical guidelines recommend at least one dilated eye exam each year for all people living with diabetes. Your retina specialist may recommend more frequent visits depending on the severity of your condition. Catching changes early gives you the most treatment options and the greatest opportunity to preserve your vision.
Everyday choices make a meaningful difference in your eye health over time. A balanced diet, regular physical activity, and maintaining a healthy body weight all support better blood sugar control. Quitting smoking, if applicable, can significantly reduce the risk of disease progression. For those who have already experienced some degree of vision loss, practical tools such as magnifying devices, large-print materials, and improved home lighting can help maintain independence in daily activities.
It is completely understandable to feel anxious or overwhelmed after a diabetic retinopathy diagnosis. Concerns about your vision and your future quality of life are valid and deserve attention. Support groups, counseling, and resources from organizations such as the American Diabetes Association and the BrightFocus Foundation can provide meaningful assistance. Staying engaged in your care plan and asking questions at each visit helps you remain informed and empowered throughout the process.
Frequently Asked Questions
The following questions address practical aspects of diabetic retinopathy that patients frequently ask about, including topics related to treatment decisions and knowing when to seek urgent care.
Treatment can slow or stop the progression of diabetic retinopathy and often improve vision, but damage that has already occurred to the retina may not be fully reversible. This distinction makes early detection so important. The sooner the condition is identified and treatment begins, the greater the opportunity to preserve the vision you currently have. Waiting until symptoms appear means some permanent damage may have already occurred.
The frequency of injections depends on the specific medication prescribed, the severity of your condition, and how your eyes respond to treatment. Most patients begin with monthly injections during a loading phase and then transition to longer intervals as the condition stabilizes. Some newer medications allow for intervals of eight to sixteen weeks or more between treatments. Your retina specialist will build a schedule tailored specifically to you, and that schedule may be adjusted over time as your condition and treatment response evolve.
Diabetic retinopathy can affect one or both eyes, and it is common for both eyes to eventually be involved, though the severity may differ significantly between them. Each eye is examined and evaluated separately at every visit, and treatment plans are developed individually for each eye based on what is found. If one eye has more advanced disease, it may require more aggressive treatment than the other.
Without treatment, diabetic retinopathy can advance to stages that cause severe and potentially irreversible vision loss. Proliferative diabetic retinopathy can lead to vitreous hemorrhage (bleeding inside the eye), traction retinal detachment (where scar tissue pulls the retina away from the wall of the eye), and neovascular glaucoma (dangerously elevated eye pressure from abnormal vessel growth). These advanced complications are considerably more difficult to manage than earlier stages of the disease, which is why ongoing monitoring and timely treatment are essential.
There is no guaranteed way to prevent diabetic retinopathy, but your risk can be reduced substantially through consistent diabetes management. Keeping blood sugar, blood pressure, and cholesterol well controlled over time are the most protective measures available. Annual dilated eye exams allow for detection before vision loss occurs, giving you the opportunity to begin treatment at the most favorable stage. If you have been recently diagnosed with diabetes, scheduling a baseline eye exam with a retina specialist early is a proactive measure that can pay dividends for years.
If your primary care physician or optometrist has identified any signs of diabetic retinopathy during a routine exam, a referral to a retina specialist is appropriate. Retina specialists have advanced training and access to specialized imaging and treatment options not typically available in a general eye care setting. You do not need a referral to contact our practice directly, and we are available to see patients on an urgent basis when symptoms require prompt evaluation. If you are experiencing any sudden changes in vision, do not wait for a scheduled appointment to seek care.
Schedule a Consultation at New England Retina Associates
Our fellowship-trained vitreoretinal surgeons are committed to delivering expert, personalized retina care to patients throughout Connecticut, whether you have been referred by your physician or are reaching out on your own. We see patients at every stage of diabetic retinopathy, from an initial baseline evaluation to the ongoing management of advanced disease. If you are living with diabetes, do not wait for symptoms to appear before scheduling an eye exam. Early evaluation is one of the most important steps you can take to protect your long-term vision.
30 Years of Care & Commitment
